Arctic Therapeutics and Nacuity Pharmaceuticals Announce European Medicines Agency Approval to Initiate First Clinical Trial of AT-001 (NPI-001) for the Treatment of HCCAA
12 mars 2024 09h00 HE
|
Nacuity Pharmaceuticals, Inc.
REYKJAVIK, Iceland and FORT WORTH, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Arctic Therapeutics ehf, an Icelandic drug development company and partner Nacuity Pharmaceuticals, Inc., a...
Next Generation Sequencing Market To Reach USD 19.12 Billion By 2026 | Reports And Data
18 sept. 2019 13h34 HE
|
Reports and Data
New York, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Government initiatives for large scale NGS based projects, collaborations for technical advancements in NGS and declining costs are key factors...
New Life Scientific, Inc. to Present at the ValueRich Small Cap Financial Exposition -- September 15, 2005
01 sept. 2005 06h20 HE
|
New Life Scientific Inc.
FREEHOLD, N.J., Sept. 1, 2005 (PRIMEZONE) -- New Life Scientific, Inc. ("New Life") (OTCBB:NWLF) www.newlifesci.com, an emerging bio-tech company, today announced that it will be a presenting company...
SmallCap Sentinel: Gauging the Impact of the Pending Horde of Baby Boomers
29 août 2005 03h30 HE
|
SmallCap Sentinel
IRVINE, Calif., Aug. 29, 2005 (PRIMEZONE) -- "While many fear the lack of investment dollars in the stock market by retiring baby boomers, savvy investors are focusing on the areas where this...
Galapagos Announces Half Year 2005 Results
12 août 2005 02h24 HE
|
Galapagos Genomics
Mechelen, Belgium, Aug. 12, 2005 (PRIMEZONE) -- Galapagos:
- Financials on target for 2005 increased annual revenues and
cash burn of around 7 million euro
- Initial public offering...
Keryx Biopharmaceuticals to Present at Banc of America Securities Annual Health Care Conference
17 mai 2005 08h29 HE
|
Keryx Biopharmaceuticals, Inc.
NEW YORK, May 17, 2005 (PRIMEZONE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), announced today that Michael S. Weiss, Chairman and Chief Executive Officer, will present an overview of the...
Galapagos Appoints Andre Hoekema as Managing Director Galadeno
12 avr. 2005 05h07 HE
|
Crucell N.V.
LEIDEN, Netherlands, April 12, 2005 (PRIMEZONE) -- Galapagos, a genomics-based drug discovery company, has appointed Dr. Andre Hoekema as Managing Director of Galadeno, Galapagos' services unit....
Actelion Ltd: Japanese Approval for Tracleer(r) in PAH
11 avr. 2005 01h31 HE
|
Actelion Ltd.
ALLSCHWIL, Switerzerland, April 11, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) announced today that the Japanese Ministry of Health, Labor and Welfare has granted formal approval...
Crucell and DSM Announce PER.C6(R) Licensing and Service Agreement with Roche for Protein Production
16 févr. 2005 02h13 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Feb. 16, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they...
Crucell Fully Compliant
26 janv. 2005 07h38 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Jan. 26, 2005 (PRIMEZONE) -- In media coverage today a suggestion was made that insider trading occurred on the exercise of options on January 18, 2005, by certain employees...